ICON Public Limited Company ICON Public Limited Company

ICON Public Limited Company

ICLR

Rangering i aksjer #1647
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Aksjekurs
$167.98
Sist synkronisert: 2026-10-19
Markedsverdi
$12.96B
Endring (1 dag)
-1.29%
Endring (1 år)
-10.86%
Land
IE
Handel ICON Public Limited Company (ICLR)

Kategori

Healthcare
Inntekter for ICON Public Limited Company (ICLR)
Inntekter i Jun 2026 TTM: $417.71M
Ifølge ICON Public Limited Company sine nyeste økonomiske rapporter er selskapets nåværende resultat $417.71M. I 2023 hadde selskapet et resultat på $624.08M, en økning sammenlignet med resultatet i 2022, som var $564.72M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for ICON Public Limited Company fra 2001 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $417.71M -51.94%
2024 $869.18M 39.27%
2023 $624.08M 10.51%
2022 $564.72M 190.31%
2021 $194.52M -48.92%
2020 $380.84M -10.81%
2019 $426.99M 15.91%
2018 $368.38M 12.42%
2017 $327.67M 9.16%
2016 $300.17M 7.65%
2015 $278.85M 37.56%
2014 $202.72M 67.72%
2013 $120.87M 79.80%
2012 $67.22M 131.84%
2011 $29.00M -68.73%
2010 $92.72M -11.42%
2009 $104.67M 6.51%
2008 $98.28M 36.54%
2007 $71.98M 39.89%
2006 $51.46M 134.06%
2005 $21.98M -36.59%
2004 $34.67M 37.13%
2003 $25.28M 30.80%
2002 $19.33M 42.18%
2001 $13.60M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$7.61B 1,721.60%
US
$4.76B 1,040.03%
US
$-252.70M -160.50%
US
- -
CN
$1.66B 296.93%
US